Quintet Private Bank (Europe) S.A. Biogen Inc. Transaction History
Quintet Private Bank (Europe) S.A.
- $1.75 Trillion
- Q3 2024
A detailed history of Quintet Private Bank (Europe) S.A. transactions in Biogen Inc. stock. As of the latest transaction made, Quintet Private Bank (Europe) S.A. holds 710 shares of BIIB stock, worth $110,355. This represents 0.01% of its overall portfolio holdings.
Number of Shares
710
Previous 647
9.74%
Holding current value
$110,355
Previous $173 Million
20.3%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding BIIB
# of Institutions
1,035Shares Held
126MCall Options Held
1.13MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.59 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.54 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.26 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.14 Billion0.06% of portfolio
-
Wellington Management Group LLP Boston, MA5.13MShares$798 Million0.18% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $22.4B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...